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The material in this report originated in the Public Health Practice
Program Office, Edward L. Baker, M.D., Director, and the Division of
Laboratory Systems, Robert Martin, Dr.P.H., Director.
Introduction
Delivery of high-quality laboratory services is essential in
our health-care system both for providing the foundation for
clinical decisions and as an objective means to measure and
monitor biological and environmental markers. In response
to an increasing concern regarding the U.S. population’s vul-
nerability to health risks, efforts have been made to reduce
preventable risks (e.g., those related to terrorist events, anti-
microbial resistance, foodborne illness, and environmental
threats). Accurate and timely laboratory analyses are critical
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Summary
Emerging natural and man-made threats to the health of the nation’s population require development of a seamless laboratory
network to address preventable health risks; this can be achieved only by defining the role of public health laboratories in public
and private laboratory service delivery. Establishing defined core functions and capabilities for state public health laboratories will
provide a basis for assessing and improving quality laboratory activities. Defining public health laboratory functions in support of
public health programs is the beginning of the process of developing performance standards for laboratories, against which state
public health laboratories, and eventually local public health and clinical laboratories, will establish and implement best labora-
tory practices. Public health is changing, and as a part of that change, public health laboratories must advocate for and implement
improvements for public health testing and surveillance. These changes are outlined also in the Association of Public Health
Laboratories consensus report (Association of Public Health Laboratories. Core functions and capabilities of state public
health laboratories: a white paper for use in understanding the role and value of public health laboratories in protecting our
nation’s health. Washington, DC: Association of Public Health Laboratories, 2000).
to identifying, tracking, and limiting public health threats and
ultimately reducing rates of preventable morbidity and mor-
tality (1–3). Optimal functioning of the public health system
to meet these threats is dependent on uniform and high-quality
laboratory testing (4). Furthermore, facing public health chal-
lenges from emerging and reemerging pathogens (e.g., West
Nile virus [5], drug-resistant communicable disease agents [6],
and Escherichia coli O157:H7 [7,8]), requires evaluation of
the functions, responsibilities, and capacities of state public
health laboratories (SPHLs) (9). This evaluation of the role of
public health laboratories includes environmental threat con-
cerns (10) and appropriate application of technological ad-
vances (i.e., tandem mass spectrometry or pulsed field gel
electrophoresis [11–13]). Certain disease prevention and con-
trol programs within CDC support and promote technical
capacity in SPHLs (e.g., PulseNet for molecular typing; Labo-
ratory Response Network for bioterrorism preparedness; Epi-
demiology and Laboratory Capacity program; and resources
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for tuberculosis, human immunodeficiency virus [HIV], sexu-
ally transmitted diseases, blood lead, and others).
A key precept for public health is recognizing that the ma-
jority of testing for public health is either performed in pri-
vate laboratories or is dependent on private laboratories for
referral and reporting. Therefore, a function of public health,
and specifically of SPHLs, is to ensure the availability, quality,
and reporting of laboratory testing performed in the private
sector. A minimal association exists between SPHLs and pri-
vate (i.e., hospital and independent) laboratories, and this lim-
ited association can lead to a lack of communication and
coordination of the laboratory testing that is necessary to sup-
port public health interventions.
An impediment to improving public-private coordination
is the disparity of functions among SPHLs, because those func-
tions evolved differently in each state. As of January 2002,
approximately 174,000 laboratories were operating in the
United States; this number included an estimated 2,000 pub-
lic health laboratories, and the remainder included hospital,
independent, and physician office laboratories (14). Labora-
tories are difficult to quantify or describe according to the
volume and scope of work they perform. SPHLs operate au-
tonomously, and delivery of public health testing historically
has been, and will continue to be, state-based. State health
systems vary in aspects that affect the delivery of quality pub-
lic health testing. For example, state health systems individu-
ally determine which diseases are reportable by laboratories or
clinicians (15). Technical standards exist for disease-specific
testing, but no standard definitions exist for the broader role
and functions of public health laboratories. Developing an
effective laboratory system for public health testing requires
definitions for standard functions of SPHLs, including a broader
role in ensuring the quality of testing throughout the state.
Since the 1980s, the HIV epidemic has emphasized SHPLs’
critical roles of assessing, leading, and developing health policy.
Public health laboratories still consist of diverse groups and
institutions (9). Public health laboratories are a loose network
of federal, state, and local laboratories that work in undefined
collaboration with private clinical laboratories (16). Disease
outbreaks during 1992–2002 have increased the recognition
of the specific testing capacities in SPHLs and reinforced the
need for improving and developing communication and co-
ordination of testing services between SPHLs and clinical labo-
ratories (17–20). After the anthrax attacks during
September–October 2001, agencies within the U.S. Depart-
ment of Health and Human Services, including CDC, estab-
lished laboratory priorities for bioterrorism preparedness.
These priorities encourage leadership functions for policy de-
velopment, laboratory improvement, and training and educa-
tion for clinical laboratory personnel. Guidelines
accompanying the FY 2002 supplemental emergency funding
for bioterrorism preparedness and response and public health
infrastructure improvement address the need for public-private
integration of laboratory functions critical to public health.
The need to develop these links is well-recognized and is the
single critical benchmark for laboratories in the Guidance for
Fiscal Year 2002 Supplemental Funds for Bioterrorism (21).
That benchmark requires developing a plan to improve work-
ing relationships and communication between clinical labo-
ratories and higher lever laboratories to ensure that core
capabilities are maintained. Core capabilities concerning
bioterrorism include 1) performing rule-out testing on criti-
cal bioterrorism agents; 2) safely packing and handling speci-
mens; and 3) referring specimens and isolates to higher level
laboratories for further testing.
The trend to better define the role of public health is appar-
ent in public health policy documents (e.g., the Essential Ser-
vices [22]). The first of the 10 essential services of public health
(i.e., monitoring health status to identify and solve commu-
nity health problems) is directly dependent on laboratory pro-
vision of analysis, pathogen identification, and disease
monitoring. The second essential service (i.e., diagnosing and
investigating health problems and health hazards in the com-
munity) is directly supported by laboratory functions (22).
The significance of the Association of Public Health Labora-
tories (APHL) core functions and capabilities of SPHLs lies
in the fact that laboratory testing is a common denominator
for fulfillment of these and the majority of public health ob-
jectives, which are designed to be met by measurable indica-
tors of goals. Attainment of these goals can only be
accomplished through performance of consistent, high-quality
laboratory testing, for which assessment requires a definition
of laboratory capabilities.
Healthy People 2010, which also shapes the role of public
health, addresses goals for building the public health infra-
structure (23). Included among the goals are increasing acces-
sibility of laboratory services and the proportion of tribal, state,
and local health agencies that provide or ensure comprehen-
sive laboratory services to support essential public health ser-
vices (Objective 23-13) (23). The definition of critical
laboratory services and its functions are described by APHL
(24), and consensus regarding these functions of public health
laboratory services is the base for assessing all laboratories.
APHL’s recommendations go beyond the traditional functions
that are acknowledged as the responsibilities of laboratory ser-
vices (i.e., specimen analysis and isolate identification, disease
control and surveillance, reference and specialized testing, and
food safety) to areas of leadership and strengthening labora-
tory infrastructure for the public health testing system (i.e.,
laboratory improvement and regulation, policy development,
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training and education, and partnership and coordination).
These recommendations for core functions enable state lead-
ers and stakeholders (e.g., state epidemiologists, state and lo-
cal health officers, and state legislators) to assess the adequacy
of the public health laboratory systems, allocate resources, and
encourage needed relationships between the public health sys-
tem and the health-care delivery system. Further, these rec-
ommendations provide a guide for assessing and monitoring
the service and value of the public health laboratories by serv-
ing as a basis for creation of policy development (25). From this
foundation, development of laboratory performance standards
and laboratory quality assurance can evolve in the United States.
Background
Development of the core functions document and this re-
port represent the culmination of activities that reflect a 1988
Institute of Medicine (IOM) report (25). The IOM report
stated, “public health, as a profession, as a governmental ac-
tivity, and as a commitment of society is neither clearly de-
fined, adequately supported, nor fully understood” (25). Since
the early 1990s, a common theme of all public health reports
has been that public health activities and practices were not
well-defined and that the mission and infrastructure neces-
sary to support public health was also not well-defined (26).
In this report, we focus on one component (the state public
health laboratories) of one critical piece of the public health
infrastructure (laboratories) and relate the consensus view of
the membership of APHL regarding the core functions and
capabilities of SPHLs.
Although state public health laboratories have been in exist-
ence for longer than 100 years, no organization had yet de-
fined necessary activities of SPHLs. However, the lack of
defined activities is understandable, considering that this group
of >50 laboratories was created independently by states and
from the outset had different charters that gave them a het-
erogeneous character. Despite their diversity, in the aggregate,
they represent a critical component of our nation’s public health
infrastructure, and public health is well-served to have a de-
fined list of core functions and capabilities that all state public
health laboratories have endorsed.
This attempt to define the core functions of SPHLs began
in approximately 1993 when APHL (then the Association of
State and Territorial Public Health Laboratory Directors) de-
veloped an internal unpublished report that addressed the need
to distinguish public health laboratories from other laborato-
ries (e.g., those in clinical and hospital settings) (G. Anderson,
A. DiSalvo, and W. Hausler in “Task Force Report on the
Public Health Laboratory: A Critical National Resource; Re-
port to the Association of State and Territorial Public Health
Laboratory Directors,” unpublished, 1993). In 1993, a per-
spective regarding the evolution of public health laboratories
since their creation was published (27).
APHL continued to review the need for a more formal defi-
nition of core functions for public health laboratories, and in
1995, an internal report (R. L. Cada, S. L. Inhorn, P. Bouchard,
J. M. Counts, and M. W. Kimberly in “Core Functions of
Public Health Laboratories: A Report to the Association of
State and Territorial Public Health Laboratory Directors by a
Task Force, unpublished, 1995) was distributed to the mem-
bership. The report started the process of more clearly identi-
fying the core functions of SPHLs and related the core
functions of laboratories to assessment, quality assurance, and
policy development — the core functions of public health
established in the 1988 IOM report (25). In 1996, profes-
sionals within the laboratory section of the American Public
Health Association issued an internal report on the role of
public health laboratories. In 1999, health officials stated that
the United States needed a national laboratory system
(17,19,20), and the General Accounting Office stated, “pub-
lic health officials have not developed a consensus definition
of the minimum capabilities that state and local health de-
partments need to conduct infectious disease surveillance” (28).
By that time, APHL had already charged its Leadership De-
velopment Task Force with developing a definitive statement
concerning the core functions of state public health laborato-
ries. APHL’s resulting strategic plan reflected the priority needs
and activities of APHL and guided their mission in defining
the role of SPHLs in two of their strategic goals for 1999–
2001: 1) to ensure that essential laboratory services are avail-
able to support public health activities in the changing
health-care environment, and 2) to advocate effectively for
public health laboratories through legislation, policy develop-
ment, and public information (29).
The work of the APHL Task Force in defining core func-
tions and capabilities of SPHLs was performed in collabora-
tion with and support from CDC’s Public Health Practice
Program Office, Division of Laboratory Systems (PHPPO/
DLS). Since 1987, APHL has had a cooperative agreement
with CDC through PHPPO/DLS. A component of this agree-
ment has focused on the National Laboratory Partnership
(NLP), which is a multifaceted program that allows collabo-
ration among APHL members, professional and scientific staff,
and CDC for work related to public health laboratory prac-
tice. NLP activities with CDC have supported APHL’s devel-
opment of this report. Representatives from PHPPO/DLS
actively participated in APHL meetings and discussions that
led to the consensus vote regarding the APHL position. The
value of defining core functions for SPHLs lies in the support
given to CDC initiatives for developing laboratory infrastruc-
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ture for testing (e.g., foodborne disease investigations and
vaccine-preventable diseases). PHPPO also views the core func-
tion report as a prerequisite to developing performance stan-
dards for public health laboratories. The report (24) was
adopted in its entirety by unanimous vote as the consensus
position of APHL at the 2000 APHL annual meeting. Those
adopted core functions are stated in this report.
These recommendations describe the broader functions and
elements that are necessary to ensure the laboratory capability
to execute the core functions. The term core function is a role
assumed by the laboratory that underlies the laboratory’s abil-
ity to support public health. The term capability denotes a
specific activity that ensures the successful implementation of
an associated function. For each capability, each state public
health laboratory has a capacity for performing a specified
number of tests within a certain time. Laboratory capacity is a
key concern in light of strengthening bioterrorism prepared-
ness and the federal mandate to address infectious disease out-
breaks, other public health threats, and emergencies (24).
This report is the beginning of a process to improve public
health testing, which will also require the definition of core
functions of public health laboratories at the local level. This
will help meet the need identified in the 1988 IOM report to
better define and understand one of the critical infrastructure
components of public health.
SPHL Core Functions
SPHLs should accomplish the following 11 core functions
as part of their organizational capacity:†
• disease prevention, control, and surveillance;
• integrated data management;
• reference and specialized testing;
• environmental health and protection;
• food safety;
• laboratory improvement and regulation;
• policy development;
• emergency response;
• public health-related research;
• training and education; and
• partnerships and communication.
The capabilities critical for SPHLs to be able to perform these
11 essential functions are designated in the following sections.
Disease Prevention, Control,
and Surveillance
• Provide accurate and precise analytical results in a timely
manner for different diagnostic and analytical functions for
assessment and surveillance of infectious, communicable,
genetic, and chronic diseases, and environmental exposures.
• Serve as a first line of defense in rapidly recognizing and
preventing the spread of communicable diseases by
— examining specimens for identifying disease outbreaks;
— isolating and identifying the causative agent;
— determining the source of infection;
— identifying carriers; and
— locating sources of infection in the environment.
• Serve as a center of expertise for the detection and identi-
fication of biologic agents of significance in human dis-
ease; as such, ensure access to laboratory expertise and





— immunology and serology;
— mycobacteriology;
— mycology; and
— hematology and immunohemotology.
• Provide specialized tests for low-incidence, high-risk dis-
eases (e.g., tuberculosis, rabies, botulism, and plague);
detect epidemiologic shifts; and detect newly emerging
pathogens, including but not limited to
— testing specimens from suspect cases of tuberculosis
to identify Mycobacterium tuberculosis infections and
determine effective antibiotic treatment;
— testing influenza specimens as directed by national and
international surveillance efforts to identify viral strains
and control influenza;
— testing animal specimens from suspected rabies carri-
ers to detect the virus and ensure that prevention mea-
sures appropriately protect humans and domestic
animals from exposure; and
— assisting public and private health-care providers in
investigating and controlling communicable or envi-
ronmental diseases.
• Provide population surveillance, or screening, for condi-
tions of interest to the public health community, includ-
ing screening for inherited neonatal metabolic disorders,
environmental toxins, immune status, risk factors, chronic
blood diseases, blood lead, and antibiotic resistance.
• Perform tests to meet specific program needs of public
health agencies.
Integrated Data Management
• Serve as the focal point for accumulating, blending, and
disseminating scientific information in support of public
health programs, including† Not listed in order of priority or significance.
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— capturing laboratory data essential for public health
analysis and decision-making;
— ensuring the ability to maintain and communicate
laboratory data by using standardized data formats;
— ensuring rapid dissemination of laboratory informa-
tion to assist in identification, understanding, and con-
trolling disease outbreaks;
— providing primary data necessary to provide informa-
tion for and implement policy and planning; and
— providing a statewide disease reporting network, with
centralized facilities for receipt, storage, retrieval, and
analysis of data.
• Participate as a key link in national database systems to
collect, monitor, and analyze laboratory data, including
as the primary data link with CDC for surveillance of
diseases of national and global concern.
• Serve the data needs of state epidemiologists, other labo-
ratories, and practitioners in identifying trends and sen-
tinel events that indicate emerging health problems.
Reference and Specialized Testing
• Serve as the state’s primary reference microbiology
laboratory to
— test for, and aid in the diagnosis of, unusual pathogens;
— confirm atypical laboratory test results;
— verify results of other laboratory tests;
— provide oversight for quality assurance;
— test epidemiologically significant specimens with
potential public health implications;
— provide reference diagnostic testing to private sector
laboratories that might not have the capability to fully
identify disease agents of public health significance;
— test for diseases of public health consequence that are
too rare or unusual for other laboratories to maintain
capacity for testing, including human genetic mark-
ers of disease; and
— provide toxicology testing, including drug, alcohol,
poison, and trace metal analyses.
Environmental Health and Protection
• Conduct scientific analyses of environmental samples (air,
water, and soil) to identify and monitor potential threats
to human health and ensure compliance with environ-
mental regulations.
• Analyze environmental and biological specimens and de-
tect, identify, and quantify toxic contaminants (e.g., lead,
pesticide residues, heavy metals, and volatile organic com-
pounds).
• Provide or ensure laboratory services that support assur-
ance of clean air in the state, by testing for particulates,
radon, and toxic compounds.
• Provide environmental chemistry testing, which includes
inorganic (e.g., nonmetals, metals, and nonmetal contami-
nants) and organic compounds (e.g., semivolatiles,
volatiles, pesticides, and herbicides).
• Provide or ensure laboratory services that support assur-
ance of clean water in the state, by analyzing water for
synthetic organic chemicals, pesticides, inorganic chemi-
cals, microorganisms, and radionuclides.
• Provide or ensure analysis of environmental samples (e.g.,
soil, dust, drinking water, and paint chips) to quantify
potential sources of exposure to hazardous substances.
• Conduct scientific laboratory analyses of environmental
samples to determine the relationship between environ-
mental hazards and human health.
• Measure toxicants to determine conclusively the extent of
a community’s exposure to environmental hazards.
• Provide industrial hygiene/occupational health testing to
assist in efforts to protect indoor air quality and workers’
health, including routine analysis of asbestos, acids,
amines, solvents, silica, metals (including lead), gases,
pesticides, radon, spores, fungi, and other analytes.
Food Safety
• Test specimens from persons, food, and beverages impli-
cated in foodborne illness outbreaks to identify causes and
sources. Testing might include assays to detect organisms
(e.g., Escherichia coli O157:H7, staphylococcus, bacillus,
salmonella, shigella, vibrio, listeria, and clostridium).
• Analyze food specimens to detect, identify, and quantify
toxic contaminants (e.g., pesticide residues, heavy metals,
and volatile organic compounds).
• Provide, or ensure, radiation-control studies to monitor




• Coordinate and promote quality assurance programs for pri-
vate clinical and environmental laboratories through train-
ing, consultation, certification, and proficiency testing.
• Serve as the standard of excellence for local and private
laboratory performance.
• Exercise leadership and authority as the agency respon-
sible for laboratory regulation and training in the clinical
and environmental areas.
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• Develop and oversee statewide quality assurance and labo-
ratory improvement programs to ensure the reliability of
laboratory data used for communicable disease control
and environmental monitoring.
• Oversee the licensure, certification, and accreditation of
laboratories to ensure that medical, environmental, food
safety, and alcohol testing laboratories fulfill state and fed-
eral mandates.
• Provide analytical support of federal, state, county, and
local regulations and laws.
Policy Development
• Provide scientific and managerial leadership in develop-
ing state and federal public health policy and in develop-
ing, promoting, and integrating public health laboratory
science into practice.
• Participate in developing standards for all health-related
laboratories, including food, environmental, clinical, and
research standards.
Emergency Response
• Provide laboratory support as part of state and national
disaster preparedness plans for environmental or health
emergencies, including
— rapidly identifying and investigating analyses of bio-
logical, chemical, and radiological agents, regardless
of the source of exposure (i.e., unintentional, terrorist,
or natural disaster);
— ensuring the capacity to quickly and accurately handle
a substantial volume of tests during an emergency situ-
ation; and
— providing a rapid response system for hazardous con-
taminants in waste spills; air, water, and soil; and in
foodborne disease outbreaks.
Public Health-Related Research
• Evaluate and implement new technologies and analytical
methodologies to ensure that laboratories provide state-
of-the-art, cost-effective, and timely analytical and diag-
nostic services and support to the public health and
health-care communities in the state, including
— identifying the need for new laboratory methodolo-
gies for disease detection and prevention;
— conducting research to improve laboratory tests for
more effective disease surveillance; and
— conducting research to develop rapid methods for labo-
ratory diagnosis.
• Collaborate with academic and private sector researchers
and other government agencies to adapt emerging tech-
nologies to public health laboratory techniques and in-
formation systems.
• Conduct applied studies into new and improved analyti-
cal methods and services that are necessary to meet chang-
ing public health surveillance and environmental
regulatory requirements.
• Provide advice to the private sector regarding newly mar-
keted tests.
Training and Education
• Sponsor training opportunities to improve scientific and
technical skills of public health laboratory staff.
• Provide, or facilitate, training courses and workshops for
laboratory staff in private and public sectors to continu-
ally upgrade the knowledge and skills essential for pro-
viding quality services in medical, environmental, and
public health laboratories.
• Provide short- and long-term training opportunities to
prepare scientists for careers in public health laboratory
practice.
• Provide continuing education in management and lead-
ership development for those in administrative positions.
• Participate in training of international scientists.
Partnerships and Communication
• Develop and strengthen statewide partnerships among
state, county, and city public health leaders, managed care
organizations, academia, and private industry to advance
understanding of the critical role played by public health
laboratories in supporting the core functions of public
health.
• Emphasize the role and value of the public health labora-
tory to state public health programs.
• Participate in state strategic policy planning and develop-
ment processes.
• Maintain strong communication networks among
— health officers/commissioners;
— county and city health officials;
— state epidemiologists;
— directors of sexually transmitted disease, tuberculosis
control, chronic disease prevention, maternal and child
health, and environmental programs;
— legislators;
— state health budget personnel;
— other laboratory management staff; and
— other state leaders.
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Conclusion
Before development of the APHL Core Functions and Ca-
pabilities of State Public Health Laboratories (24), a concise
and thorough definition of public health laboratory functions
in support of public health programs did not exist. Typically,
public health laboratories had been recognized only for the
service they provided in analyzing specimens, both human
and environmental, and for identification and confirmation
of microorganisms. Funding was available for these visible
functions of the laboratory, but recognition and noncategorical
funding was not available for functions related to infrastruc-
ture, including training and workforce development; commu-
nication among laboratories, medical colleagues, and the
public; and leadership for laboratory personnel. Certain ex-
ternal activities directly related to the analysis function have
not been recognized (e.g., transport of isolates and specimens
to referral laboratories — the cost and logistics have been left
to the individual laboratories, both public and private, to work
out on their own [state-supported laboratory transport sys-
tems exist in only a limited number of states]).
The APHL core functions and this report are advancements
in understanding the unique roles and activities provided by
public health laboratories in the United States. Other national
public health activities — including bioterrorism prepared-
ness — will benefit from recognition of these roles and func-
tions. The timing of efforts that are the logical outgrowth of
the core functions is critical during this period of strengthen-
ing public health infrastructure and preparedness for
bioterrorist events and other public health emergencies. The
definition of laboratory core functions will provide a basis for
assessment and improvement of laboratory activities, followed
by policy development and quality assurance.
The National Laboratory System, a cooperative initiative of
CDC and APHL, is dependent on and supportive of the labo-
ratory core functions, including those external functions that
integrate with clinical laboratories. The National Laboratory
System is a strategic priority for APHL and includes the ob-
jectives of assessing and monitoring private and public labo-
ratory capacities, increasing coordination and communication
among laboratories, and building partnerships between pub-
lic and private laboratories, workforce development through
training and education, and promotion of laboratory stan-
dards. As federal guidelines have emphasized the need for ef-
fective working relationships and communication between
clinical laboratories and higher-level laboratories, pilot projects
in four states have demonstrated the benefits of systematic
integration of laboratories, with attention toward upgrading
laboratory function.
Another key continuation of the definition of laboratory
core functions is the need to develop performance standards.
Performance standards are critical for public health in provid-
ing potential benefits of improved accountability; better re-
source deployment; enhanced capacity building for
community, state, and national public health systems; wide-
spread use of best practices; and increased focus on mission
and goals (30). The same premise is true for benefits of per-
formance standards for laboratories. Work is in progress to
create performance standards for the nation’s laboratories
through collaborative efforts of APHL and CDC.
The outcome from the definitions within the APHL 2000
Consensus White Paper on the Core Functions and Capabili-
ties of State Public Health Laboratories will extend through
the following needed initiatives:
• performance standards for state public health laboratories;
• a coordination of laboratory efforts through a national
system, which will strengthen public health laboratories
and establish connections with local public health and
private laboratories;
• definition of core functions and performance standards
for local public health laboratories; and
• performance standards.
Collectively, these efforts will enable all laboratories in the
United States to actively support and participate in major
public health activities that keep the population healthy and
free of disease and unhealthy environmental exposures.
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The material in this report originated in the National Center on Birth
Defects and Developmental Disabilities, José F. Cordero, M.D., Director,
and the Division of Birth Defects and Developmental Disabilities, Joseph
Mulinare, M.D., M.S.P.H., Acting Director.
Background
Prenatal alcohol use is one of the leading preventable causes
of birth defects and developmental disabilities. According to
the 1999 Behavioral Risk Factor Surveillance System, 12.8%
of women reported drinking alcohol during pregnancy (1).
Children exposed to alcohol during fetal development can
suffer multiple disorders that range from subtle changes in
I.Q. to profound mental retardation. They can also suffer
growth retardation and be born with birth defects of major
organ systems. One of the most severe outcomes is fetal alco-
hol syndrome (FAS), which includes central nervous system
disorders, growth retardation, and facial malformations. CDC
studies have documented FAS prevalence rates ranging from
0.2 to 1.5/1,000 live births (2–4).
FAS was first described in scientific literature in the United
States approximately 30 years ago (5). Since that time, ad-
vancements have been made in FAS diagnostics, surveillance,
prevention, and interventions. Disorders related to prenatal
alcohol exposure have generated substantial interest and ac-
tivity among CDC’s partners (e.g., federal, state, and local
agencies; school systems; academicians and clinicians; advo-
cates; and families) and affected persons. However, additional
work still needs to be done to prevent prenatal alcohol-related
disorders and effectively intervene with children and families
affected by them. Problems that still need to be addressed in-
clude 1) raising public awareness regarding the dangers of al-
cohol use during pregnancy and the adverse outcomes
associated with prenatal alcohol exposure (i.e., FAS and other
alcohol-related effects); 2) educating and training health and
social service professionals concerning how to identify and
intervene with women at risk for alcohol-exposed pregnan-
cies; 3) developing effective intervention programs for chil-
dren affected by prenatal alcohol exposure; 4) promoting and
supporting basic research to identify the etiology and mecha-
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Summary
Prenatal alcohol exposure can lead to serious birth defects and developmental disabilities. A need exists to develop effective
strategies for both children with fetal alcohol syndrome (FAS) or other prenatal alcohol-related effects and for women at high risk
for having an alcohol-exposed pregnancy. Since the syndrome was identified approximately 30 years ago, advancements have been
made in FAS diagnostics, surveillance, prevention, and intervention, but a substantial amount of work remains. Collaborations
among partners in federal, state, and local agencies, academia, clinical professions, school systems, and families are critical to
developing and implementing successful efforts related to FAS and fetal alcohol effect (FAE). In 1999, Congress directed the
Secretary of the U.S. Department of Health and Human Services to convene the National Task Force on FAS and FAE (the Task
Force). CDC’s National Center on Birth Defects and Developmental Disabilities, Fetal Alcohol Syndrome Prevention Team,
coordinates the Task Force and manages its operation. Since the Task Force was chartered in 2000, Task Force members, with
input from multiple partners, have convened to deliberate and determine the Task Force mission, goals, and priority concerns to
be addressed. This report describes the structure, function, mission, and goals of the Task Force and provides their first recommen-
dations. An explanation of how the Task Force recommendations were generated and the Task Force’s next steps are also reported.
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nisms involved in FAS; and 5) improving the quality of life of
affected persons and families.
Introduction
In 1998, the U.S. Congress recognized the significance of a
coordinated effort to address the concerns related to FAS and
fetal alcohol effect (FAE). The Secretary of the U.S. Depart-
ment of Health and Human Services (DHHS) was directed
through the Public Health Service Act, Section 399G (42
U.S.C. Section 280f, as added by Public Law 105-392) to
establish a National Task Force on Fetal Alcohol Syndrome
and Fetal Alcohol Effect (the Task Force) that would 1) foster
coordination among all governmental agencies, academic bod-
ies, and community groups that conduct or support FAS and
FAE research, programs, and surveillance; and 2) otherwise
meet the needs of populations impacted by FAS and FAE. On
May 17, 2000, in accordance with Public Law 92-463, the
Task Force was chartered. Authority to establish the Task Force
was delegated to CDC’s National Center on Birth Defects
and Developmental Disabilities (NCBDDD). NCBDDD’s
Fetal Alcohol Syndrome Prevention Team was assigned pri-
mary responsibility for establishing the Task Force and man-
aging its operations. The Task Force function, as outlined in
its charter (6), is to
• advise persons involved in federal, state, and local pro-
grams and research activities of FAS and FAE regarding
such topics as FAS awareness and education for relevant
service providers and the general public (including school-
aged children and women at risk), medical diagnosis for
FAS and FAE, prevention and intervention strategies for
women at risk, and essential services for affected persons
and their families;
• coordinate its efforts with the DHHS Interagency Coor-
dinating Committee on Fetal Alcohol Syndrome
(ICCFAS); and
• report, on a biennial basis, to the DHHS Secretary and
relevant committees of Congress on the current and
planned activities of the participating agencies.
The Task Force includes 12 members and the chair. Mem-
bers are selected by the DHHS Secretary, or designee, from
authorities knowledgeable in FAS and FAE, including mem-
bers of the academic community; clinicians; representatives
from federal, state, and local government agencies and offices;
parents or legal guardians of persons with FAS and FAE; and
representatives from advocacy and research organizations.
ICCFAS, coordinated through the National Institute of Alco-
holism and Alcohol Abuse (NIAAA), is a committee of repre-
sentatives from federal agencies working on FAS-related
activities. The chair of the ICCFAS is a standing member of
the FAS/FAE Task Force. Partners regularly attend the Task
Force meetings and play a vital role in the process.
Task Force Methods
After committee appointments were confirmed, the Task
Force convened to identify priority concerns. In December
2000, during the Task Force’s inaugural meeting, working
groups were formed to begin addressing key priorities. In keep-
ing with recommendations from the Institute of Medicine
Committee on FAS, the Task Force used the term alcohol-
related neurodevelopmental disorder (ARND) to denote cases
with evidence of central nervous system neurodevelopmental
abnormalities that have been linked in clinical or animal re-
search to prenatal alcohol exposure, but that do not meet the
diagnostic criteria for FAS (7). ARND prevalence is believed
to be approximately three times greater than FAS (8). The
Task Force engaged in a strategic planning process to clarify
its role by creating a mission statement and goals. The Task
Force’s mission is to prevent FAS and ARND and to promote
effective, lifelong interventions for those affected. Task Force
goals are to 1) advise and foster coordination among all state,
local, and federal agencies; tribal councils; and other private
entities regarding FAS and ARND concerns; 2) promote com-
munication and education regarding the adverse conditions
associated with prenatal alcohol use; 3) identify research needed
to develop effective strategies for preventing and treating FAS
and ARND; 4) assess what services are available and identify
gaps in needed services for women at risk and persons affected
by prenatal alcohol exposure; and 5) ensure that appropriate
diagnostic and treatment services are made available to women
at risk for an alcohol-exposed pregnancy and to children and
adults with FAS and ARND. By using its mission statement
and goals as a foundation, the Task Force developed recom-
mendations regarding the most critical concerns.
Task Force Recommendations
Through a consensual group process, occurring first in work-
ing groups and then with the full committee, the Task Force
generated its first recommendations. Certain Task Force mem-
bers are scientists knowledgeable in FAS and ARND whose
ideas are based on the best evidence to date; however, the fol-
lowing recommendations also incorporate the insights of mem-
bers who care for or provide services to affected children or
provide substance abuse services to women at risk for an
alcohol-exposed pregnancy. The initial working groups were
combined into two major groups, the Research Working
Group and the Services and Public Awareness Working Group.
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The purpose of the Research Working Group was to evalu-
ate existing FAS and ARND research and make recommenda-
tions concerning needed actions to remedy deficiencies in
high-priority areas. This group generated recommendations
1–6. The Services and Public Awareness Working group iden-
tified concerns that need to be explored to ensure the avail-
ability of high-quality, effective services for women at risk for
an alcohol-exposed pregnancy and for persons with FAS or
ARND, and to achieve an increased level of visibility and public
awareness regarding concerns of prenatal alcohol use, FAS,
and ARND. This group generated recommendations 7–15.
Task Force recommendations are as follows:
1. Develop a clinical case definition for diagnosing FAS,
including a neurocognitive phenotype, and begin work
on establishing a clinical case definition for ARND.
2. Develop a uniform surveillance case definition for FAS
and begin formative work on a uniform surveillance
case definition for ARND.
3. Develop a white paper to review and summarize relevant
epidemiologic research addressing the scope of the
problem, prevalence, risk factors, impediments to
diagnosis, and number of women at risk for an alcohol-
exposed pregnancy.
4. Develop a white paper to review the evidence for
effective prevention and treatment strategies for women
at risk for or engaging in prenatal alcohol use. The report
should describe women at risk, identify barriers to
implementing effective strategies, and proscribe against
implementation of untested models or models that are
not evidence-based.
5. Develop a health services research agenda focusing on
families of persons with FAS and ARND that address
such concerns as why certain families do well and stay
together, the impact of FAS and ARND on families
relative to other birth defects, and how the legal system
deals with FAS and ARND.
6. Develop a science research agenda, including translational
research that brings basic research findings to the clinical
domain (e.g., neuroimaging), and address concerns of
maternal and fetal susceptibility to FAS and ARND.
7. Complete a profile of state, tribal, and private entities
with existing services for persons with FAS and ARND
and women at risk for an alcohol-exposed pregnancy;
the profile should include eligibility criteria and ongoing
educational efforts for professionals regarding FAS and
ARND.
8. Develop an agenda that will lead to a national standard
of care for persons with FAS and ARND during their
life span, including best practices and plans for
dissemination of standards to relevant health-care
professionals.
9. Endorse a national coordinated media campaign and
request that ICCFAS recommend how to coordinate
this effort among all federal agencies.
10. Endorse the U.S. Surgeon General’s Advisory statement
regarding drinking during pregnancy, and urge that the
statement be reissued as part of the coordinated national
media campaign.
11. Contact the Office of National Drug Control Policy to
recommend inclusion of information regarding FAS and
ARND in their resource materials.
12. Develop a checklist of essential state services needed to
prevent FAS and ARND, to treat persons with FAS and
ARND and their families, and to better identify women
at risk for having an alcohol-exposed pregnancy.
13. Develop and disseminate a plan for systemwide
education regarding prenatal alcohol-related disabilities
to be offered to professionals in health services, judicial
services, education, child welfare, vocational
rehabilitation, juvenile justice, maternal child health
clinics, and disabilities services and prevention.
14. Develop and disseminate a kindergarten–grade 12
curriculum to address FAS, ARND, and prenatal alcohol
use.
15. Investigate incorporating information related to
prevention and treatment of FAS and ARND into the
credentialing requirements for teachers, juvenile justice
workers, lawmakers, and health-care professionals (e.g.,
include FAS-related questions on state board exams).
Next Steps
As a first step, the Task Force has been working closely with
CDC and other federal agencies to address these recommen-
dations in a comprehensive and coordinated fashion. Because
work in areas related to the recommendations is already un-
der way, and expertise exists across federal agencies, collabo-
ration between the FAS/FAE Task Force and ICCFAS is
essential. Next steps include identifying which agency will take
the lead on each recommendation and collaborating with part-
ners within and outside of the federal system to devise an imple-
mentation plan for these recommendations.
Certain initiatives already under way focus on the Task Force
recommendations. In 2002, CDC received a Congressional
mandate to develop guidelines to diagnose FAS and other con-
ditions resulting from prenatal alcohol exposure, incorporate
these guidelines into the curricula of medical and allied health
students and practitioners, and disseminate curricula to and
provide training for the target audiences regarding these guide-
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lines. CDC will coordinate this activity with the Task Force
to develop diagnostic and surveillance guidelines for FAS.
These efforts address Task Force recommendations 1 and 2.
In addition, CDC recently solicited proposals to fund four
regional training centers for the education and training of
medical and allied health students and professionals concern-
ing FAS and other prenatal alcohol-related disorders. These
centers will develop, conduct, and analyze population-based
surveys of medical and allied health students and practitio-
ners to understand their knowledge, attitudes, and beliefs re-
garding the diagnosis, treatment, and prevention of FAS and
other prenatal alcohol-related disorders. The surveys will also
assess respondents’ previous training experiences, practices, and
educational needs, and barriers to diagnosis and treatment.
On the basis of these findings and a review of existing cur-
ricula, the centers will develop, implement, and evaluate edu-
cational curricula for medical and allied health students and
practitioners that incorporate diagnostic guidelines for FAS
and other prenatal alcohol-related disorders. This effort ad-
dresses the education-related recommendations, specifically
recommendations 13 and 15.
The FAS Center for Excellence, administered by the Center
for Substance Abuse Prevention, Substance Abuse and Men-
tal Health Services Administration, was recently established
under section 519D of the Children’s Health Act of 2000.
The FAS Center for Excellence has conducted a series of town
hall meetings across the United States to gather information
regarding the concerns of FAS- and ARND-affected families
and communities. These findings will provide further infor-
mation for implementing the recommendations, including the
recommendations related to public awareness of FAS and
ARND prevention and the availability of services. In addi-
tion, the FAS Center for Excellence has initiated an environ-
mental scan aimed at highlighting model programs for FAS
prevention and treatment and identifying gaps in existing ser-
vice delivery systems. These activities address recommenda-
tions 5, 7, and 8. NIAAA sets the basic sciences research agenda
for FAS and other prenatal alcohol-related outcomes and sup-
ports its implementation through the National Institutes of
Health grant process (recommendation 6). NIAAA also con-
venes and chairs the ICCFAS and, thus, has lead responsibil-
ity for ensuring coordination of efforts among federal agencies
in addressing FAS and ARND (recommendations 9 and 10).
Ongoing challenges for the Task Force include developing
strategies to enhance implementation of the recommendations
in this report as well as others that will be released throughout
the term of this chartered committee. Task Force meetings are
held approximately twice a year and are open to the public.
Meeting notices are published in the Federal Register. Further
information regarding the Task Force and minutes of previ-
ous meetings can be accessed at http://www.cdc.gov/ncbddd/
fas/taskforce.htm.
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